What would it cost to license or integrate this prosthetic technology?+
Based on available project data, specific licensing costs are not disclosed. The technology involves multiple components (implant, mechatronic coupler, sensorized hand, control algorithms) developed across 10 partners in 4 countries, so licensing would likely need to be negotiated with several parties. The coordinator is Scuola Superiore Sant'Anna in Italy.
Can this be manufactured at industrial scale?+
The project produced both alpha and beta versions of the prosthetic hand and mechatronic coupler, showing iterative hardware development. However, the system was tested on only 3 patients in a clinical centre, indicating it is still in the clinical validation stage rather than mass production readiness. Scale-up would require regulatory approval (CE marking/MDR) and manufacturing partnerships.
What is the IP situation and who owns the patents?+
Based on available project data, IP ownership details are not publicly disclosed. The consortium includes 10 partners (5 universities, 2 research organizations, 1 industry partner, and 2 other entities) across Italy, Sweden, Switzerland, and the UK. IP is likely shared among consortium members under the Horizon 2020 grant agreement terms.
What regulatory approvals would be needed?+
As an implantable medical device with neural interfaces, this technology would require rigorous regulatory clearance — CE marking under the EU Medical Device Regulation (MDR) and FDA approval for US markets. The 3-patient clinical trial provides initial safety and efficacy data, but larger clinical studies would be needed before market authorization.
How long before this reaches the market?+
The project ran from 2016 to 2021 and achieved clinical implantation in 3 patients with both alpha and beta prosthesis iterations. Based on the deliverable progression from alpha to beta versions, the hardware is maturing but would still need expanded clinical trials and regulatory approval. A realistic timeline to market would depend on a commercial partner committing to the regulatory pathway.
How does this integrate with existing prosthetic systems?+
The system was designed specifically for transradial (below-elbow) amputees, which the project identifies as the largest population of upper limb amputees. It requires surgical osseointegration — a bone-anchored implant — so it is not a drop-in replacement for existing socket-based prosthetics. The mechatronic coupler connects the implant to the prosthetic hand, creating a self-contained system.
Is there ongoing support or follow-up development?+
The project closed in August 2021. The consortium includes Scuola Superiore Sant'Anna (coordinator) and partners in Sweden, Switzerland, and the UK with strong track records in prosthetics research. Based on available project data, follow-up projects or commercial spin-offs are not confirmed but the research group has continued publishing in this area.
